NCT06991075 Transcutaneous Electrical Nerve Stimulation for Pain Mitigation During Intrauterine Device Placement
| NCT ID | NCT06991075 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of South Carolina |
| Condition | Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 86 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 86 participants in total. It began in 2025-12-01 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Investigators are conducting a study to determine whether high frequency transcutaneous electrical nerve stimulation (hfTENS) is effective at reducing pain in women having an IUD inserted.
Eligibility Criteria
Inclusion Criteria: * Provision of signed and dated informed consent form for IUD Insertion * Stated willingness to comply with all study procedures * English speaking individuals aged 18 years or older * Presenting for IUD initiation during ambulatory care visit at MUSC Women's Health * Opting for either LNG 52mg or copper T380A IUD Exclusion Criteria: * Contraindication to IUD initiation (i.e. pregnancy, current pelvic infection, distorted uterine anatomy) * Contraindication or allergy to ibuprofen * History of a chronic pain disorder * Recent opioid use in the previous 30 days * History of a cardiac arrhythmia * History of heart disease (i.e. atrial fibrillation, congestive heart failure) * Presence of an implantable device with an electrical discharge (i.e. pacemaker) * BMI \> 50 (class IV obesity) * History of TENS use * Planned pain intervention outside standard of care (i.e. paracervical block, misoprotol) OR preprocedure use of non-standard pain medication (i.e. benzodiazepines, marijuana, muscle relaxers, gabapentin, benadryl) * History of epilepsy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06991075 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06991075 currently recruiting?
Yes, NCT06991075 is actively recruiting participants. Contact the research team at paynej@musc.edu for enrollment information.
Where is the NCT06991075 trial being conducted?
This trial is being conducted at Charleston, United States.
Who is sponsoring the NCT06991075 clinical trial?
NCT06991075 is sponsored by Medical University of South Carolina. The trial plans to enroll 86 participants.